You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T Cell Infusion

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cystic Fibrosis, Pancreatic Insufficiency, Abnormal Glucose Tolerance Trial in Philadelphia (Dulaglutide 0.75Mg/0.5Ml Inj Pen)

Recruiting
  • Cystic Fibrosis
  • +3 more
  • Dulaglutide 0.75Mg/0.5Ml Inj Pen
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 11, 2023

Functional Magnetic Resonance Imaging in Preoperative Assessment

Recruiting
  • Penile Cancer
  • Multi-parametric, functional magnetic resonance imaging (MRI)
  • Oslo, Norway
    Oslo University Hospital
Jul 7, 2022

Stage IV NSCLC Trial (Ramucirumab, Docetaxel)

Withdrawn
  • Stage IV Non-small Cell Lung Cancer
  • (no location specified)
Jun 8, 2020

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)

Recruiting
  • Graft-versus-host Disease
  • New York, New York
    NYU Langone Health
Mar 24, 2022

Peripheral Blood Single Cell Sequencing Analysis of POD and CPSP

Not yet recruiting
  • Postoperative Delirium
  • Chronic Postsurgical Pain
    • (no location specified)
    Oct 5, 2022

    Diabetes Trial in United States (Extended Infusion Set)

    Completed
    Has Results
    • Diabetes
    • Extended Infusion Set
    • Little Rock, Arkansas
    • +14 more
    Sep 29, 2021

    Tinnitus, Subjective Trial in Chicago (Transcranial Direct Current Stimulation)

    Completed
    • Tinnitus, Subjective
    • Transcranial Direct Current Stimulation
    • Chicago, Illinois
      Center for Translational Imaging at Northwestern University
    Jan 10, 2023

    Cutaneous Squamous Cell Carcinoma Trial in Tampa (Pramlintide)

    Suspended
    • Cutaneous Squamous Cell Carcinoma
    • Tampa, Florida
      Moffitt Cancer Center
    Dec 30, 2022

    Advanced Renal Cell Carcinoma Trial in United States (Dalantercept and axitinib, Placebo and axitinib)

    Terminated
    Has Results
    • Advanced Renal Cell Carcinoma
    • Dalantercept and axitinib
    • Placebo and axitinib
    • Tucson, Arizona
    • +35 more
    Sep 12, 2022

    Targeting of the Latent HIV Infected Reservoir to Cure HIV

    Recruiting
    • HIV Infections
    • +2 more
      • Rotterdam, Netherlands
        Erasmus Medical Centre
      Jan 17, 2022

      Retinitis Pigmentosa Trial in Tuebingen (subretinal injection of rAAV.hPDE6A)

      Active, not recruiting
      • Retinitis Pigmentosa
      • subretinal injection of rAAV.hPDE6A
      • Tuebingen, Germany
        Universitätsklinikum Tübingen, Department für Augenheilkunde
      Dec 7, 2022

      ed in Chronic Obstructive Pulmonary Disease Patients

      Not yet recruiting
      • Vestibular Disorder
      • Respiratory Assessment
      • +2 more
      • (no location specified)
      Dec 1, 2022

      Relapsed/Refractory Diffuse Large B Cell Lymphoma Trial in Seoul (Glofitamab, Poseltinib, Lenalidomide)

      Recruiting
      • Relapsed/Refractory Diffuse Large B Cell Lymphoma
      • Glofitamab, Poseltinib, Lenalidomide
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Nov 28, 2022

      Cardiac Troponin T and Troponin I in Diagnosis of Myocardial

      Recruiting
      • Myocardial Infarction
      • Troponin T and I
      • Bispebjerg, Copenhagen, Denmark
      • +1 more
      Jul 6, 2022

      Advanced or Metastatic Merkel Cell Carcinoma, Advanced or Metastatic Cutaneous Squamous Cell Carcinoma, Advanced or Metastatic

      Terminated
      • Advanced or Metastatic Merkel Cell Carcinoma
      • +4 more
      • Tucson, Arizona
      • +25 more
      Mar 30, 2022

      Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells

      Recruiting
      • Pediatric Cancer
      • Collection of post mortem tissue donation
      • Chicago, Illinois
        Ann & Robert H. Lurie Children's Hospital of Chicago
      Nov 3, 2021

      NSCLC Trial in Suzhou (Envafolimab Injection)

      Recruiting
      • NSCLC
      • Envafolimab Injection
      • Suzhou, Jiangsu, China
        Northern Jiangsu People's Hospital
      Oct 29, 2023

      Anesthesia Trial in Cairo (Aminophylline bolus then infusion, aminophylline bolus, normal saline)

      Recruiting
      • Anesthesia
      • Aminophylline bolus then infusion
      • +2 more
      • Cairo, Egypt
        Kasr Alainy
      Dec 30, 2022

      Trichuriasis, Ascariasis, Hookworm Infections Trial in Chake Chake (moxidectin (8 mg) / albendazole (400 mg), ivermectin (200

      Completed
      • Trichuriasis
      • +3 more
      • moxidectin (8 mg) / albendazole (400 mg)
      • +4 more
      • Chake Chake, Pemba, Tanzania
        Public Health Laboratory Ivo de Carneri
      Jan 31, 2022

      Healthy Trial in London (Bread product (standard milled), Bread Product (micro-milled), Bread Product (standard aleurone))

      Recruiting
      • Healthy
      • Bread product (standard milled)
      • +3 more
      • London, United Kingdom
        King's College London
      Sep 7, 2022

      Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Japan (Tazemetostat)

      Completed
      Has Results
      • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
      • Nagoya, Aichi, Japan
      • +27 more
      Nov 18, 2022

      COVID-19 Trial (Convalescent plasma)

      Available
      • COVID-19
      • Convalescent plasma
      • (no location specified)
      Dec 10, 2021

      Pain, Postoperative Trial (Ketorolac Tromethamine, Morphine Sulfate, Intravenous Placebo for NTM-001)

      Recruiting
      • Pain, Postoperative
      • Ketorolac Tromethamine
      • +3 more
      • Pasadena, Maryland
      • +5 more
      Dec 28, 2022

      Tumors by Site Trial in Worldwide (nivolumab, rHuPH20)

      Active, not recruiting
      • Neoplasms by Site
      • Atlanta, Georgia
      • +35 more
      Jan 6, 2023

      Squamous Cell Carcinoma in Situ Trial in United States (STP705, Placebo Saline)

      Active, not recruiting
      • Squamous Cell Carcinoma in Situ
      • Scottsdale, Arizona
      • +5 more
      Dec 13, 2022